To examine further the protective capability of CCK1R activation in SCA Purkinje cells, we assessed the ability of this CCK1R agonist to improve Purkinje cell function in transgenic mouse models of SCA1 and SCA2 [20]. The gene discussed is CCKAR; the disease is spinocerebellar ataxia type 1.